ACP-105(CAS 899821-23-9)Muscle mass gain,Fat reduction Steroids

ACP-105 is a novel, non-steroidal selective androgen receptor modulator (SARM) originally developed for the treatment of degenerative conditions such as osteoporosis and muscle-wasting diseases.As a SARM, its primary therapeutic appeal lies in its tissue-selective mechanism. Unlike traditional anabolic steroids, ACP-105 is designed to target and activate androgen receptors specifically in skeletal muscle and bone tissue while exhibiting minimal activity in other organs, thereby significantly reducing the risk of undesirable androgenic side effects like prostate enlargement or virilization. Preclinical models indicate it offers strong anabolic potency, contributing to enhanced lean muscle mass and bone density.